47/100BSempra stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Sempra is 95.06, 21.6% above the current price of 78.18. Their targets range from 83.00 to 108.00.
Of the 13 firms that rated Sempra in the past 12 months, 10 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 83.00 to 108.00, with an average of 95.06.
| Buy | 10 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 108.00 |
| Average target | 95.06 |
| Lowest target | 83.00 |
| Current price | 78.18 |
Sempra price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Sempra price target and rating?
How analysts rate Sempra, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
10 of 13 firms rate it buy now, against 7 of 10 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Sempra analyst upgrades, downgrades and price targets
The latest rating change came on 1 September 2026, when Jefferies upgraded Sempra from Hold to Buy. Its price target is 97.00, from 101.00. The most recent new target came from HSBC on 22 October 2026: 97.50.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 22 Oct 2026 | HSBC | — | 97.50 | — | 83.50 |
| 20 Oct 2026 | BTIG | — | 106.00 → 100.00 | -5.7% | 81.74 |
| 14 Oct 2026 | Truist Financial Richard Sunderland | Reiterated · Buy | 96.00 → 94.00 | -2.1% | 82.37 |
| 12 Oct 2026 | Barclays Nicholas Campanella | Reiterated · Overweight | 103.00 → 90.00 | -12.6% | 81.34 |
| 29 Sept 2026 | Scotiabank | — | 83.00 | — | 76.90 |
| 3 Sept 2026 | Truist Financial Richard Sunderland | Reiterated · Buy | 100.00 → 96.00 | -4.0% | 83.80 |
| 1 Sept 2026 | Jefferies | Upgraded · Hold → Buy | 101.00 → 97.00 | -4.0% | 81.70 |
| 31 Aug 2026 | Mizuho Securities | Downgraded · Outperform → Neutral | 84.00 | — | 84.32 |
| 13 Aug 2026 | Truist Financial | Reiterated · Buy | 104.00 → 100.00 | -3.8% | 86.53 |
| 22 Jul 2026 | Morgan Stanley David Arcaro | — | 105.00 → 108.00 | +2.9% | 92.88 |
| 22 Jul 2026 | BMO Capital | Reiterated · Outperform | 99.00 → 102.00 | +3.0% | 92.79 |
| 16 Jul 2026 | Jefferies | — | 89.00 → 101.00 | +13.5% | 92.78 |
| 9 Jul 2026 | Barclays | Reiterated · Overweight | 105.00 → 103.00 | -1.9% | 95.15 |
| 24 Jun 2026 | Morgan Stanley | — | 104.00 → 105.00 | +1.0% | 91.90 |
| 18 May 2026 | Truist Financial | Reiterated · Buy | 108.00 → 104.00 | -3.7% | 90.43 |
| 21 Apr 2026 | Morgan Stanley | Reiterated · Overweight | 101.00 → 104.00 | +3.0% | 93.27 |
| 21 Apr 2026 | Wells Fargo | — | 112.00 → 118.00 | +5.4% | 93.38 |
| 20 Apr 2026 | Truist Financial Richard Sunderland | — | 108.00 | — | 93.38 |
| 15 Apr 2026 | Barclays | Reiterated · Overweight | 95.00 → 105.00 | +10.5% | 96.16 |
| 4 Mar 2026 | Argus Research | Upgraded · Hold → Buy | — | — | — |
| 20 Feb 2026 | Morgan Stanley | — | 97.00 → 101.00 | +4.1% | 93.35 |
| 3 Feb 2026 | Barclays Nicholas Campanella | Reiterated · Overweight | 97.00 → 95.00 | -2.1% | 86.22 |
| 2 Feb 2026 | Morgan Stanley David Arcaro | Reiterated · Overweight | 95.00 → 97.00 | +2.1% | 86.81 |
| 22 Jan 2026 | UBS | Reiterated · Neutral | 92.00 → 100.00 | +8.7% | 85.98 |
| 22 Jan 2026 | UBS | — | 96.00 → 92.00 | -4.2% | 85.98 |
| 22 Jan 2026 | Barclays Nicholas Campanella | Reiterated · Overweight | 101.00 → 97.00 | -4.0% | 85.98 |
| 21 Jan 2026 | Morgan Stanley | — | 91.00 → 95.00 | +4.4% | 84.89 |
| 20 Jan 2026 | Wells Fargo Shahriar Pourreza | Reiterated · Overweight | 115.00 → 112.00 | -2.6% | 92.55 |
| 17 Dec 2025 | UBS | Reiterated · Neutral | 96.00 | — | 87.91 |
| 16 Dec 2025 | Morgan Stanley | — | 98.00 → 91.00 | -7.1% | 88.57 |
| 20 Nov 2025 | Morgan Stanley | — | 99.00 → 98.00 | -1.0% | 91.12 |
| 14 Nov 2025 | Goldman Sachs | Upgraded · Neutral → Buy | — | — | — |
Sempra EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Sempra's EPS to grow 29.7% a year until 2028. Over the last 5 years it fell 15.6% a year, and over the last 3 years it fell 6.0%.
Analysts expect Sempra's revenue to fall 0.4% a year until 2028. Over the last 5 years it grew 3.8% a year, and over the last 3 years it fell 4.1%.
Revenue
EPS
Does Sempra beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 7.7% off the result, either way, and their revenue estimate 11.4%, over the last 12 quarters.
- EPS beats
- 91 / 136
- Revenue beats
- 77 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +4.3%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | 1.22 | 1.40 | +14.8% | 3.31B | 3.19B | -3.7% |
| Q2 FY2026 | 6 Aug 2026 | 1.01 | 1.16 | +14.9% | 3.14B | 3.00B | -4.5% |
| Q1 FY2026 | 7 May 2026 | 1.51 | 1.51 | 0.0% | 4.10B | 3.66B | -10.9% |
| Q4 FY2025 | 26 Feb 2026 | 1.24 | 1.28 | +3.2% | 4.05B | 3.75B | -7.4% |
| Q3 FY2025 | 5 Nov 2025 | 0.91 | 1.11 | +21.8% | 2.93B | 3.18B | +8.5% |
| Q2 FY2025 | 7 Aug 2025 | 0.85 | 0.89 | +5.2% | 3.10B | 3.00B | -3.1% |
| Q1 FY2025 | 8 May 2025 | 1.32 | 1.44 | +9.1% | 3.92B | 3.80B | -2.9% |
| Q4 FY2024 | 25 Feb 2025 | 1.47 | 1.50 | +2.0% | 4.36B | 3.76B | -13.8% |
| Q3 FY2024 | 6 Nov 2024 | 1.05 | 0.89 | -15.2% | 3.54B | 2.78B | -21.6% |
| Q2 FY2024 | 6 Aug 2024 | 0.94 | 0.89 | -5.3% | 3.46B | 3.01B | -12.9% |
| Q1 FY2024 | 7 May 2024 | 1.34 | 1.34 | 0.0% | 5.58B | 3.64B | -34.7% |
| Q4 FY2023 | 27 Feb 2024 | 1.12 | 1.13 | +0.9% | 4.01B | 3.49B | -13.1% |
Sempra stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Sempra's earnings keep growing at the 8.4% a year analysts expect to FY2028, it would earn about 7.05 a share in FY2030. At the P/E it has traded at over the last five years (15.5 to 32.9) that is 109.62 to 231.89 a share, or 164.80 at its average P/E of 23.4. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 5.17 | 80.31 | 120.73 | 169.89 |
| FY2027 | 5.51 | 85.69 | 128.83 | 181.28 |
| FY2028 | 6.01 | 93.36 | 140.35 | 197.49 |
| FY2029 (extrapolated) | 6.51 | 101.16 | 152.08 | 214.00 |
| FY2030 (extrapolated) | 7.05 | 109.62 | 164.80 | 231.89 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 8.4% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (15.5, 23.4, 32.9).
Is Sempra stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Sempra's P/E of 16.7 is below the middle of its 5-year range (8.8 to 36.1, median 17.9). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Fair value is not a reliable guide for Sempra: its earnings swing (EPS fell 37.8% in FY2025), so its usual P/E would mislead. Its forward P/E, on the consensus for FY2026, is 15.1.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 16.67
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 17.86
- Five-year P/E range
- 8.8 – 36.1
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 15.13
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.99
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +21.6%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 64.525 | 127.9762Price 64.53185 | +98.3% | |
| 28.410 | 56.3234Price 28.4196 | +98.2% | |
| 153.725 | 297.58169Price 153.73471 | +93.6% | |
| 243.002 | 464.71205Price 243.00627 | +91.2% | |
| 160.085 | 305.52160Price 160.09396 | +90.8% | |
| 37.565 | 71.4258Price 37.57193 | +90.1% | |
| 160.240 | 300.28225Price 160.24375 | +87.4% |
Furthest below the fair value on each stock's page, updated every day.